SAA restricts T cell mediated anti-tumor immunity by limiting antigen presentation in lung cancer

Mei Huang(Central South University), Bo Shen(Sir Run Run Shaw Hospital), Chunbin Wang(Yancheng Third People's Hospital), Feng Jiang(University of British Columbia), Guoren Zhou(Jiangsu Cancer Hospital), Shaodi Wen(Jiangsu Cancer Hospital), Xin Wang(Jiangsu University), Yihan Zhang(Tianjin University of Technology), Cong Xu(Jiangsu Cancer Hospital), Xiaoyue Du(Inner Mongolia Agricultural University), Run Shi(Jiangsu Province Hospital)
Frontiers in Immunology
December 19, 2025
10.3389/fimmu.2025.1735479
Cited by 0

Related Papers

The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human Genome
|Science|2002|370
Grain yield prediction of rice using multi-temporal UAV-based RGB and multispectral images and model transfer – a case study of small farmlands in the South of China
|Agricultural and Forest Meteorology|2020|299
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
|Gastroenterology|2019|225